The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute ...

C3.ai is driving growth beyond oil and gas, with rising traction in manufacturing, government and life sciences in fiscal 2025.

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies ...

Organisations need future-ready leadership and Bella Ikpasaja FCMI has made it her life’s mission to provide it ...

Basic Earnings Per Share (EPS): Basic EPS rose 56.8% from RMB 0.37 for the six months ended June 30, 2024 to RMB 0.58 for the six months ended June 30, 2025. Diluted EPS increased by 57.1% from RMB ...

Gaurav Batra, through his company GSK Company Ltd, ran The Kebabs Takeaways in Dinsdale and Garden Place, and a cleaning ...

The FTSE 100 Live index reflects real-time movements of the top UK companies. FTSE 100 opened slightly higher on Tuesday, ...

Aptar Pharma’s Freepod® spray pump used with Haleon’s Otrivin® Nasal Spray is made of 52% ISCC Plus certified bio-based ...

GSK is also acquiring Affinivax' pipeline, which includes a 30-valent pneumococcal shot in preclinical development as well as candidates for Klebsiella pneumoniae and Pseudomonas aeruginosa ...

The GSK deal is another endorsement of Flagship's strategy of creating companies based on biopharma technology platforms, often putting its faith in high-risk ventures, to attract deep-pocketed ...